New Publication: Reaksi Drug Safety News - Issue 3/2017 Print User Rating: 1 / 5 Please Rate Vote 1 Vote 2 Vote 3 Vote 4 Vote 5 REAKSI Drug Safety News, Issue 3/2017 Loperamide: Risk of Serious Cardiac Adverse Events with High Doses, Including Through Misuse Thalidomide, Lenalidomide and Pomalidomide: Risk of Hepatitis B Reactivation, Herpes Zoster and Pulmonary Hypertension DOWNLOAD PDF